BLUE - Bluebird Bio Company Long-Term Debt

Brandmark of bluebird bio Inc. (BLUE)

The price history on the GURU.Markets platform helps assess the impact of liquidity shortages and costly procedures on the stability of bluebird bio, Inc. (BLUE). bluebird bio, Inc. (BLUE) is implementing automated bioreactors to eliminate human error during vector creation, while its strategy focuses on developing one-time curative treatments for hereditary blood pathologies, replacing traditional lifelong management. The current metric is 0.00.

BLUE (bluebird bio, Inc.) Company Long-Term Liabilities history from 07/04/2022 to 06/07/2025

Bluebird Bio (BLUE) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price bluebirdbio.com|BLUE - Analyst Consensus Forecast
- market capitalization statistics:
Market Value bluebird bio|BLUE - Total Company Value
- business book valuation details:
Net Assets per Single Share bluebird bio|BLUE - Company Net Assets|Market Capitalization to Book Value Ratio bluebirdbio.com|BLUE - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital bluebird bio, Inc.|BLUE - Long-Term Debt to Capital|Short-Term Debt to Equity bluebird bio, Inc|BLUE - Company Aggregate Debts|Debts to Net Assets bluebird bio|BLUE - Company Long-Term Debt|Company Short-Term Loans and Borrowings bluebird bio|Immediate Liquidity Ratio bluebirdbio.com
- net income and valuation multiples indicators:
BLUE - Net Income
Summary company analytics:BLUE bluebirdbio.com
Manufactured product of bluebird bio, Inc

Finding a balance between cost and business quality requires an analysis of the liability structure. This indicator tracks confirmed long-term borrowings, making it possible to identify abnormal deviations in credit load from the norm. For bluebird bio, Inc. (BLUE), such spikes often signify the funding of costly R&D within the gene therapy niche. Rising debt increases the risk of cash flow gaps when competing with CRISPR platforms. Assessing the company's long-term debt helps monitor the issuer's financial stability.

Competitors of bluebird bio, Inc. (BLUE)

Company Long-Term Debts Tempus Labs TEM|Qiagen - Company Long-Term Debts|IONS: Company Long-Term Debt|Repligen Corp. (RGEN) - Company Long-Term Debt|RNA (Avidity Corp) - Company Long-Term Debt|Company Long-Term Liabilities CRSP|Company Long-Term Debts genedx.com|Company Long-Term Debts RARE|BEAM - Long-Term Debt|Company Long-Term Debts SRPT (Sarepta Therapeutics Inc)|Twist Bioscience Corp - Company Long-Term Debt|10x Genomics, Inc. - Company Long-Term Debts|Long-Term Debt Volume intelliatx.com NTLA|Stoke Therapeutics, Inc. (STOK) - Company Long-Term Debt|BioLife Solutions Inc - Company Long-Term Loans and Borrowings|WVE (Wave Life Sciences Corp) - Company Long-Term Debts|Company Long-Term Indebtedness MAZE (Maze Therapeutics Corp)|Company Long-Term Liabilities SION (Sionna Therapeutics Inc)|PRME (primemedicine.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts TSHA (Taysha Gene Therapies, Inc.)|uniQure NV - Company Long-Term Debt|MeiraGTx PLC - Company Long-Term Debts|Long-Term Debt Volume REGENXBIO Corp RGNX|Solid Biosciences Inc. (SLDB) - Company Long-Term Debt|Long-Term Debt ocugen.com (OCGN)|Company Long-Term Liabilities PACB|BNTC: Company Long-Term Loans and Borrowings|Company Long-Term Debts DSGN|Long-Term Debt Volume Rocket Corp|Company Long-Term Debt 4D Molecular Therapeutics FDMT|LXEO: Company Long-Term Indebtedness|Korro Bio, Inc - Company Long-Term Debts|Editas Medicine Inc (EDIT) - Company Long-Term Liabilities|SLN (Silence Therapeutics Inc.) - Company Long-Term Liabilities|PRQR - Long-Term Debt Volume|CDXS (Codexis Inc) - Company Long-Term Debts|Company Long-Term Debt SGMO|Company Long-Term Debt Nautilus Biotechnology (NAUT)|Company Long-Term Debt MGX (Metagenomi Inc.)|Precision BioSciences - Company Long-Term Liabilities|Company Long-Term Debts Generation Bio Co GBIO|Boundless Bio, Inc. - Company Long-Term Debts|Long-Term Debt Exicure, Inc.|IMNN: Company Long-Term Debts|Company Long-Term Indebtedness PHIO|Company Long-Term Debt Mustang Bio Inc|Company Long-Term Indebtedness RNAZ (TransCode)|Company Long-Term Debts BNGO|Company Long-Term Debts adnas.com (APDN)|Company Long-Term Debts IPA (ImmunoPrecise Antibodies Ltd.)|Omega Therapeutics Inc - Company Long-Term Debt|OMIC - Company Long-Term Debt|RGLS: Company Long-Term Debt|SYRS (Syros Pharmaceuticals) - Company Long-Term Liabilities|telesisbio.com (TBIO) - Company Long-Term Debts|TCON (TRACON Pharmaceuticals, Inc.) - Company Long-Term Debts|Long-Term Debt Unity Biotechnology Inc. UBX